MASI.NASDAQMasimo CORP

Form 4: Masimo Corp COO Bilal Muhsin Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Bilal Muhsin, Chief Operating Officer of Masimo Corp, reports acquisition of stock and derivative securities, including stock options and restricted stock units, along with shares withheld for tax obligations.

Summary

  • Bilal Muhsin, the Chief Operating Officer of Masimo Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On February 28, 2024, Muhsin acquired 2,010 shares of common stock at $0, and disposed of 745 shares at $128.7 to cover tax obligations.
  • The filing also notes the withholding of 7,701 shares in 2021 and 4,919 shares in 2022 by the issuer to satisfy tax obligations related to vesting restricted stock units.
  • On March 1, 2024, Muhsin was granted 11,954 non-qualified stock options with an exercise price of $126.49, vesting over five years.
  • Additionally, Muhsin received 30,000 restricted stock units (RSUs) on March 1, 2024, with 50% vesting on March 1, 2025, and the remaining 50% vesting on March 1, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation. There are no significantly positive or negative implications.

Positives

  • The granting of stock options and restricted stock units to the COO aligns his interests with the long-term performance of the company.

Negatives

  • The disposal of shares to cover tax obligations reduces the executive's holdings, although this is a common practice.

Future Outlook

The vesting schedules of the stock options and restricted stock units suggest a focus on long-term performance and retention of the COO.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices for executives at Masimo Corp.

Comparison to Industry Standards

  • Stock option grants and RSU awards are common compensation tools used by companies like Masimo (MASI), Medtronic (MDT), and Edwards Lifesciences (EW) to incentivize and retain key executives.
  • The vesting schedules, typically ranging from 3 to 5 years, are in line with industry norms to ensure long-term commitment.
  • Tax withholding practices, where companies withhold shares to cover tax obligations upon vesting, are standard practice across the industry.

Stakeholder Impact

  • The granting of equity-based compensation can positively impact shareholder value by aligning management's interests with those of the shareholders.
  • Employees may view the executive compensation package as fair and competitive, potentially boosting morale.

Key Dates

DateDescription
02/26/2021Reporting Person was granted performance restricted stock units which vested on February 28, 2024.
02/28/2024Date of common stock transaction and vesting of performance restricted stock units.
03/01/2024Grant date of non-qualified stock options and restricted stock units.
03/01/2025Vesting date for 50% of the restricted stock units granted on March 1, 2024.
03/01/2026Vesting date for the remaining 50% of the restricted stock units granted on March 1, 2024.
03/01/2034Expiration date for the non-qualified stock options granted on March 1, 2024.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.